Duck tembusu virus envelop E protein inhibitory peptide and application thereof
A duck Tembusu virus, protein inhibition technology, applied in the direction of application, antiviral agent, peptide/protein composition, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] In the present embodiment, the screening of duck Tembusu virus envelope E protein inhibitory peptide comprises the following steps:
[0023] 1) Preparation of DTMUV HN1 strain envelope E protein by conventional method
[0024] According to the gene sequence of the E protein of DTMUV HN1 strain published by GenBank (serial number: JQ669731), use DNAStar software to analyze, design a pair of specific primers P1 and P2, and add restriction enzyme sites EcoR I and Xba I to both ends of the primers respectively and protective bases (synthesized by Takara Company), the underlined part is the enzyme cleavage site.
[0025] Upstream primer P1: 5'-CCG GAATTC TTCAGCTGTCTGGGGATGCA-3' (such as SEQ ID NO: 2, the underlined part is the EcoR I restriction site);
[0026] Downstream primer P2: 5'-CGA TCTAGA ATTGACATTTACTGCCAGG-3' (such as SEQ ID NO: 3, the underlined part is the Xba I restriction site).
[0027] Conventional methods extract DTMUV HN1 strain RNA (viral RNA extra...
Embodiment 2
[0055] In this embodiment, the application of duck Tembusu virus envelope E protein inhibitory peptide in the preparation of medicines against duck Tembusu virus disease includes the following steps: take the duck Tembusu virus envelope E protein inhibitory peptide after purification and freeze-drying powder (duck Tembusu virus envelope E protein inhibitory peptide is synthesized by solid-phase peptide synthesis, purified by reverse high-performance liquid chromatography, and the purity after purification and freeze-drying reaches more than 95%), and commonly used starch, sucrose, Talcum powder is mixed to obtain the tablet medicine for inhibiting the proliferation of duck Tembusu virus. The duck Tembusu virus envelope E protein inhibitory peptide is used as the main antiviral active ingredient in the antiviral drug. The content of each tablet of the main drug is 0.1g. The percentage content is 50%. Alternatively, the peptide powder is dissolved in PBS buffer to prepare peptid...
Embodiment 3
[0057] In this embodiment, the application of the duck Tembusu virus envelope E protein inhibitory peptide in the preparation of feed additives for inhibiting the duck Tembusu virus proliferation comprises the following steps: freezing the duck Tembusu virus envelope E protein inhibitory peptide after purification dry to obtain a polypeptide powder with a purity of more than 95% (purification adopts high performance liquid chromatography, and freeze-drying adopts freeze-drying method). 0.2-0.5‰ duck Tembusu virus envelope E protein inhibitory peptide can be added according to the feed weight, that is, 200-500 grams of peptide powder can be added per ton of feed.
PUM
Property | Measurement | Unit |
---|---|---|
diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com